510(k) K150602
K150602 is an FDA 510(k) premarket notification submitted by Guangzhou Wondfo Biotech Co., Ltd. for the device "CR3 Keyless Split Sample Cup Morphine - Methamphetamine". The FDA issued a decision of Substantially Equivalent on April 7, 2015. The device falls under product code DNK (Thin Layer Chromatography, Morphine), a Class II device regulated under 21 CFR 862.3640. Guangzhou Wondfo Biotech Co., Ltd. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 7, 2015
- Date Received
- March 10, 2015
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Thin Layer Chromatography, Morphine
- Device Class
- Class II
- Regulation Number
- 862.3640
- Review Panel
- TX
- Submission Type